New insider activity at Medpace Holdings ( (MEDP) ) has taken place on September 5, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Susan E. Burwig, the Executive Vice President of Operations at Medpace Holdings, recently sold 10,000 shares of the company’s stock, amounting to a total transaction value of $4,800,000.
Recent Updates on MEDP stock
In the last 24 hours, Medpace Holdings has experienced notable analyst activity, with several firms adjusting their price targets for the stock. Rothschild & Co Redburn downgraded Medpace to Neutral from Buy, citing valuation concerns following a recent rally in the stock’s price. Meanwhile, Mizuho, Truist, and Baird have all raised their price targets, reflecting a positive outlook on the company’s future performance. These changes are influenced by Medpace’s recent strong performance and market dynamics, prompting analysts to reassess their valuations.
Spark’s Take on MEDP Stock
According to Spark, TipRanks’ AI Analyst, MEDP is a Outperform.
Medpace Holdings scores well due to robust financial performance and positive earnings call sentiment, highlighting strong revenue growth and improved guidance. Technical analysis indicates bullish momentum, though valuation concerns arise from a high P/E ratio. The absence of a dividend yield and potential overbought technical indicators slightly temper the overall score.
To see Spark’s full report on MEDP stock, click here.
More about Medpace Holdings
YTD Price Performance: 44.09%
Average Trading Volume: 498,098
Technical Sentiment Signal: Buy
Current Market Cap: $13.55B